It shares the presence of main neuropathological features, i.e., fibrillar amyloid-β (Aβ) and hyperphosphorylated tau, with late-onset AD (LOAD; age > 65), but clinical features and other characteristics tend to differ between EOAD and LOAD [1]. The gene discussed is MAPT; the disease is Alzheimer disease.